DHX9-IN-2

CAS No. 2973395-71-8

DHX9-IN-2( —— )

Catalog No. M37315 CAS No. 2973395-71-8

DHX9-IN-2 is an inhibitor targeting ATP-dependent RNA de-helicase A (DHX9) with anticancer and antitumor activity for cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 149 Get Quote
5MG 242 Get Quote
10MG 376 Get Quote
25MG 753 Get Quote
50MG 1178 Get Quote
100MG 1872 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DHX9-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    DHX9-IN-2 is an inhibitor targeting ATP-dependent RNA de-helicase A (DHX9) with anticancer and antitumor activity for cancer research.
  • Description
    DHX9-IN-2 (example 31)is an inhibitor of ATP-dependent RNA helicase A (DHX9), with the IC50 of 0.0698 nM that has antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    DNA/RNA Synthesis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2973395-71-8
  • Formula Weight
    421.92
  • Molecular Formula
    C18H16ClN3O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (237.01 mM; Ultrasonic )
  • SMILES
    O=C(NC1=CC(Cl)=CC(=C1)NS(=O)(=O)C)C=2SC=C(C2)C=3N=CC=CC3C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. DANIELS Matthew H., et al. Preparation of imidazopyridines, thienopyrimidines, pyrrolopyrimidines and related heterocycles as inhibitors of RNA helicase DHX9 useful in treatment of cancers. World Intellectual Property Organization, WO2023154519 A1 2023-08-17
molnova catalog
related products
  • 2’-Deoxy-2’-fluoro-β...

    2’-Deoxy-2’-fluoro-β-D-arabinocytidine hydrochloride is a cytosine nucleoside analog with inhibitory effects on DNA methyltransferase , with potential antimetabolic and antitumor activity.

  • Cytembena

    Cytembena is a cytostatic and a carcinogenic compound that may increase the incidence of fibroadenomas.Cytembena broadly inhibits DNA biosynthesis.

  • Asimadoline

    Asimadoline is a proprietary small molecule therapeutic, originally developed to treat peripheral pain such as arthritis.